Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.62 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.54 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.33 |
| ▸ | ITGAV | P06756 | 1/20 | 0.33 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Pyrrolidone SCHEMBL11253981 | 1.00 | OR51E2 (0.62) | OR51E2CRBNFKBP5LMNAKDM4E | |
| 2-Pyrrolidone SCHEMBL10583107 | 0.94 | OR51E2 (0.56) | OR51E2CRBNFKBP5LMNAKDM4E | |
| Caprolactam SCHEMBL2325626 | 0.92 | CRBN (0.61) | OR51E2CRBNFKBP5LMNAKDM4E | |
| 2-Pyrrolidone SCHEMBL2489556 | 0.86 | OR51E2 (0.60) | OR51E2CRBNFKBP5KDM4EGAA | |
| 2-Pyrrolidone SCHEMBL27650892 | 0.86 | OR51E2 (0.60) | OR51E2CRBNFKBP5LMNAKDM4E | |
| 2-Pyrrolidone SCHEMBL10798548 | 0.85 | OR51E2 (0.46) | OR51E2CRBNFKBP5LMNAKDM4E | |
| Fumaric Acid SCHEMBL9716897 | 0.85 | OR51E2 (0.65) | OR51E2CRBNFKBP5LMNAKDM4E | |
| Fumaric Acid SCHEMBL9716900 | 0.85 | OR51E2 (0.65) | OR51E2CRBNFKBP5LMNAKDM4E | |
| Maleic Acid SCHEMBL1737647 | 0.85 | OR51E2 (0.65) | OR51E2CRBNFKBP5LMNAKDM4E | |
| 2-Pyrrolidone SCHEMBL27486853 | 0.85 | OR51E2 (0.54) | OR51E2CRBNFKBP5KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118308029-A | Chemical mechanical polishing solution | 齐芯微(绍兴)电子材料科技有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-114349922-B | Flexible dual-cured resin composition and preparation method of molded body thereof | 浙江华峰新材料有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-113121747-B | Photosensitive resin and preparation method and application thereof | 浙江华峰新材料有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-114349922-A | Flexible dual-curing resin composition and preparation method of forming body thereof | 浙江华峰新材料有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-113121747-A | Photosensitive resin and preparation method and application thereof | 浙江华峰新材料有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-109266261-A | A kind of student's environmentally protective glue and preparation method thereof | 喻泰阁 | 2019-01-25 | — | — | CN | claimed |
| CN-104797661-A | Multifunctional coating structure and method for forming the same | SAMSUNG ELECTRONICS CO LTD | 2015-07-22 | — | — | CN | claimed |
| US-20080274296-A1 | ENERGY-CURABLE COATING/ADHESIVE COMPOSITIONS CONTAINING CHLORINATED POLYOLEFINS | SCOTT LEVI F | 2008-11-06 | — | — | US | claimed |
| US-20040228998-A1 | Curable film preform compositions | PERMATEX, INC. | 2004-11-18 | — | — | US | claimed |
| WO-2004098472-A1 | TRANSDERMAL DELIVERY SYSTEMS AND METHODS | WATSON PHARMACEUTICALS, INC. (US) | 2004-11-18 | — | — | WO | claimed |
| US-20040202704-A1 | Transdermal delivery systems and methods | WATSON PHARMACEUTICALS, INC. | 2004-10-14 | — | — | US | claimed |
| EP-0557087-B1 | Aqueous aerosol hair-spray compositions with a relatively low content of volatile organic compounds | REVLON CONSUMER PROD CORP (US) | 1995-12-06 | — | — | EP | claimed |
| CN-114349922-B | Flexible dual-cured resin composition and preparation method of molded body thereof | 浙江华峰新材料有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-117244117-A | Medical catheter surface coating processing method and coating composition | 安徽翰兴医疗科技有限公司 | 2023-12-19 | — | — | CN | disclosed |
| US-20230047848-A1 | ADDITION CURABLE SILICONE ADHESIVE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-02-16 | — | — | US | disclosed |
| EP-4073193-A1 | ADDITION CURABLE SILICONE ADHESIVE COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| US-20040202704-A1 | Transdermal delivery systems and methods | WATSON PHARMACEUTICALS, INC. | 2004-10-14 | — | — | US | disclosed |
| CN-1385921-A | Projel composition, its dehydration method, secondary cell and double electric layer capacitor | NISSHIN SPINNING (JP) | 2002-12-18 | — | — | CN | disclosed |
| WO-1997030092-A2 | HYDROGELS | INNOVATIVE TECHNOLOGIES LIMITED (GB) | 1997-08-21 | — | — | WO | disclosed |
| EP-0332336-A2 | Antimicrobial composition | KURITA WATER INDUSTRIES LTD. (JP) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040202704-A1 | Transdermal delivery systems and methods | LPXN, GNRHR, TECR | OR51E2 2095/4885CRBN 4394/4885FKBP5 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.